Jonas Renz

403 total citations
6 papers, 58 citations indexed

About

Jonas Renz is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Jonas Renz has authored 6 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Pharmacology. Recurrent topics in Jonas Renz's work include MicroRNA in disease regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Adenosine and Purinergic Signaling (1 paper). Jonas Renz is often cited by papers focused on MicroRNA in disease regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Adenosine and Purinergic Signaling (1 paper). Jonas Renz collaborates with scholars based in Germany and Estonia. Jonas Renz's co-authors include Leslie Carstensen Floren, Susanne Harnisch, Claus Vogelmeier, Timm Greulich, Holger Garn, Jens M. Hohlfeld, Meike Müller, Ursula Homburg, Frauke Pedersen and Dawn Harper and has published in prestigious journals such as Gastroenterology, European Respiratory Journal and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jonas Renz

5 papers receiving 58 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Renz Germany 3 24 12 10 10 8 6 58
Sagar Lonial United States 2 14 0.6× 6 0.5× 7 0.7× 4 0.4× 5 0.6× 2 52
Suhua Zhou China 4 76 3.2× 7 0.6× 15 1.5× 20 2.0× 11 1.4× 5 125
LI Fen China 5 21 0.9× 5 0.4× 12 1.2× 2 0.2× 5 0.6× 20 81
Shuaijun Zhu China 4 28 1.2× 4 0.3× 7 0.7× 4 0.4× 12 1.5× 4 75
Lisa Schulz Germany 6 11 0.5× 3 0.3× 5 0.5× 42 4.2× 15 1.9× 12 108
Yacine Haddad France 5 19 0.8× 13 1.1× 11 1.1× 3 0.3× 8 1.0× 5 100
Alfred A. Vichot United States 4 20 0.8× 2 0.2× 8 0.8× 4 0.4× 8 1.0× 5 66
E S Fedenko Russia 8 21 0.9× 69 5.8× 6 0.6× 7 0.7× 2 0.3× 48 240
Bartholomeus T. van den Berge Netherlands 3 39 1.6× 2 0.2× 4 0.4× 9 0.9× 16 2.0× 8 82

Countries citing papers authored by Jonas Renz

Since Specialization
Citations

This map shows the geographic impact of Jonas Renz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Renz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Renz more than expected).

Fields of papers citing papers by Jonas Renz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Renz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Renz. The network helps show where Jonas Renz may publish in the future.

Co-authorship network of co-authors of Jonas Renz

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Renz. A scholar is included among the top collaborators of Jonas Renz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Renz. Jonas Renz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Reischl, Markus, et al.. (2021). Development of an Experimental Setup for Real-Time In-Line Dissolved Ozone Measurement for Medical Therapy. Ozone Science and Engineering. 44(5). 499–509. 4 indexed citations
2.
Greulich, Timm, Jens M. Hohlfeld, Petra Neuser, et al.. (2018). A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial. Respiratory Research. 19(1). 55–55. 34 indexed citations
3.
Atreya, Raja, Tanja Kühbacher, H Schmitt, et al.. (2018). DOP055 Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients. Journal of Crohn s and Colitis. 12(supplement_1). S069–S070.
4.
Atreya, Raja, Tanja Kuehbacher, H Schmitt, et al.. (2018). 817 - Topical Administration of a Gata-3 Specific Dnazyme Suppresses Mucosal Inflammation in a Randomized Trial with Moderate-To-Severe Ulcerative Colitis Patients. Gastroenterology. 154(6). S–169. 1 indexed citations
5.
Homburg, Ursula, Agnieszka Turowska, Jens Kuhlmann, et al.. (2013). Safety profile and pharmacokinetics of SB010, an inhaled GATA-3-specific DNAzyme, in phase I clinical trials in healthy and asthmatic subjects. European Respiratory Journal. 42(Suppl 57). 4858–4858. 2 indexed citations
6.
Floren, Leslie Carstensen, Uwe Christians, Joseph Zimmerman, et al.. (1999). Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole. Clinical Pharmacology & Therapeutics. 65(2). 159–159. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026